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ABSTRACT
Adenosine deaminases-acting-on-RNA (ADAR)
proteins induce adenosine-to-inosine editing in
double-stranded RNA molecules. This editing gen-
erates RNA diversity at the post-transcriptional
level, and it has been implicated in the control of
cell differentiation and development. The editing of
microRNA (miRNA) precursors, along with Tudor-SN
(Snd1) activity, could lead to the elimination of
selected miRNAs and reprogram miRNA activity.
Here, we report the dynamics of adenosine-to-
inosine editing in miRNA precursors and their
selected elimination during mouse preimplantation
development. Adar1p110 and Snd1 were found to be
strongly but differentially expressed in oocytes and
zygotes with respect to later pre-implantation
stages. When the biogenesis of miR-151 was
assessed, the majority of miR-151 precursors
was edited and subsequently eliminated during
early development. Deep sequencing of this and
other miRNAs confirmed that, in general, edited
precursors were selectively eliminated at early
post-zygotic stages. Moreover, in oocytes and
throughout the zygote-to-blastocyst stages,
Tudor-SN accumulated in newly discovered aggre-
gates termed ‘T bodies’. These results provide new
insight into how editing and Tudor-SN-mediated
elimination of miRNA precursors is regulated
during early development.
INTRODUCTION
MicroRNAs (miRNAs) are endogenous, non-coding
RNAs of 22 nucleotides that regulate gene expression
by targeting messenger RNAs (mRNAs). By binding to
complementary regions in mRNAs, miRNAs repress the
translation or they induce the degradation of their target
transcripts (1). The miRNAs are transcribed as longer
RNAs by polymerase II, called primitive miRNAs (pri-
miRNAs), with regions able to generate double-stranded
structures and loops owing to their sequence complemen-
tarity. Pri-miRNAs are turned into pre-miRNAs by the
DROSHA and DGCR8 protein complex, and once
exported to the cytoplasm, these pre-miRNAs can be
processed by the RNase DICER, which eliminates any
single-stranded regions to generate a duplex miRNA
molecule. The ﬁnal production of active mature forms
of single-stranded miRNAs involves the activity of
a protein complex that includes members of the
Argonaute family (2).
From Caenorhabditis elegans to humans, adenosine-to-
inosine (A-to-I) editing represents a post-transcriptional
modiﬁcation of double-stranded RNA, including
miRNA precursors (3–5). Adenosine (A) is converted to
inosine (I) through speciﬁc deamination by the adenosine
deaminases-acting-on-RNA (ADAR) family of enzymes.
Inosine is recognized as guanosine (G) by the cell machin-
ery, which affects the subsequent processing of edited mol-
ecules. Recent evidence indicates that A-to-I editing in
miRNA precursors (pri- and pre-miRNAs) affects the
RNA interference pathway (5–8), which may modulate
speciﬁc miRNA–mRNA interactions, or lead to miRNA
retargeting (9–11). When A-to-I-edited miRNA precur-
sors are not recognized as substrates by DROSHA/
DGCR8 or DICER, they may be degraded by the
Tudor-SN nuclease that is encoded by the Snd1 gene.
Tudor-SN recognizes the inosine residues in these mol-
ecules, and it actively participates in the degradation of
hyper-edited dsRNAs (12,13).
A-to-I editing is associated with cell differentiation and
development. ADAR is most strongly expressed and active
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in the brain and testis (14–16), and it is also crucial in
embryonic erythropoiesis (17). In the mouse, three genes
code for the different ADAR proteins: Adar1, Adarb1 and
Adarb2 (also called Adar1, Adar2 and Adar3, respectively).
Adar1 can produce two transcripts depending on the
promoter used for their transcription, Adar1p150
(also known as Adar1L) and Adar1p110 (or Adar1S).
Moreover, although both Adar1 and Adarb1 can be
detected in many tissues, the expression of Adarb2 has
only been detected in the brain, and it is considered to be
inactive (5). Signiﬁcantly, Adar1 mRNA is a target of
microRNA-1 (miR-1) (18), which is in turn required for
embryonic haematopoiesis and regulates the differenti-
ation of skeletal myoblasts (19). However, Adar1 regulates
miR-1 expression via the A-to-I editing of pri-miR-1 in
other cell types (11). This feedback between miR-1 and
Adar1 may therefore be crucial in cell differentiation.
To understand the potential modulatory role of miRNA
editing in fertilization and during pre-implantational
development, the expression of all the ADAR genes was
assessed by quantifying the accumulation of their tran-
scripts between the oocyte and blastocyst stages of mouse
development. The results obtained were compared with
those for mouse brain and testis where A-to-I editing is
very active. The expression of miR-1 as a potential regula-
tor of Adar transcripts was also examined, and the
dynamics of miRNA biogenesis and elimination were
studied by analysing the expression of miR-151 (which is
thought to be edited in the brain) (10).
The presence of A-to-I-edited miRNA precursor mol-
ecules, and of A-to-I-edited mature miRNAs, was
recorded during the biogenesis of mir-151 at different
pre-implantation stages. The lowest levels of mature
edited molecules were detected in the oocyte and zygote,
coinciding with the maximal accumulation of Adar1p110
and Snd1 transcripts. This suggests that both active
editing and the degradation of edited precursor RNA mol-
ecules occur during the perifertilization period. This was
conﬁrmed by the identiﬁcation of other editable miRNAs
expressed in oocytes and zygotes by deep sequencing.
Immunolocalization studies showed that the distribution
of Tudor-SN changed from a pattern of small, dispersed
aggregates in the oocyte, to one of absolute dispersal
between the zygotic and 8-cell stage, and ﬁnally to a
pattern of large aggregates in the morula and blastocyst,
herein referred to as ‘T bodies’.
MATERIALS AND METHODS
Animals
All procedures relating to the care and handling of
C57BL6 and DBA/6J mice were carried out in the CIB-
CSIC bioterium under speciﬁc pathogen-free, temperature
(22±1C) and humidity-controlled (50–55%) conditions.
All animals were housed on a 12 h light/dark cycles with
ad libitum access to food and water. Animal care and
handling was carried out in accordance with the regula-
tions of the Bioethics Committee of the Consejo Superior
de Investigaciones Cientı´ﬁcas (CSIC) that approved the
study (permit #: PI071007) and adhering to the
European Commission guidelines (directive 2010/63/EU).
Oocyte/embryo collection
Oocytes, zygotes and developing pre-implantation
embryos were collected and processed as described previ-
ously (20). Groups of 10 cells or embryos were used for
each reverse transcription-quantitative polymerase chain
reaction (RT-qPCR) analysis.
Oligonucleotides
The oligonucleotides used for PCR were designed using
ProbeFinder v.2.20 software (Roche), and they were as
follows: GGGTCTTGATCGGGGAGA (Adar1p110-F); G
CTGCCAGAGAGAGGAAGTG (Adar1p110-R); GCCGG
CACTATGTCTCAAG (Adar1p150-F); GCTGGAAACT
CCTAGGGTAAGAC (Adar1p150-R); ATCCCGCCTGT
GTAAGCA (Adar2-F); GACTCGTGGTATGTGTAGGC
(Adar2-R); CCACAGGATGGAGGGAATC (Adar3-F); G
CACTGAAGTGGGGAGACTT (Adar3-R); TCTACATC
GACTACGGCAACA (Snd1-F); GTGCTGAAGGCAGGT
GGTA (Snd1-R), ACAGCGAGCCATCCTGGCGTA
(H2afz-F); TTCCCGATCAGCGATTTGTGGA (H2afz-
R); CGCGTCTCCTTCGAGCTGTTTG (Ppia-F); TGTA
AAGTCACCACCCTGGCACAT (Ppia-R); GCATGACG
TCTGCTTTGGA (U6-F); CCACAATCATTCTGCC
ATCA (U6-R); TGATGGAGCGCTTTCCTG (pri-
miRNA-151-F); CTCGAGGAGCTCACAGTCTAGTA
(pre-miRNA-151-F); GTCCTCAAGGAGCCTCAGTC
(pri- and pre-miR-151-R). The primers and speciﬁc Taq-
Man probes for miRNA analysis were acquired from
Applied Biosystems, and the IDs for each primer are as fol-
lows: miR-151-3p (ID#001190); miR-151-3p (edited at the
+3 position: SO#65632707); miR-151-3p (edited at the 1
and+3 positions: SO#186307388); miR-1 (ID#002222).
Expression of ADAR and Snd1 genes by RT-qPCR
RT reactions, followed by qPCR, were performed on
whole oocyte or pre-implantation embryo lysates in the
presence of NP-40 (21). After denaturation at 95C for
5min, RNA was retrotranscribed by adding the lysate
to 10 ml of a mixture containing the following: 2.5 mM
Oligo dT17, 1X First-Strand Buffer (Invitrogen), 0.01M
dithiothreitol, 2U of RNAsin (RNase inhibitor:
Promega), 0.5mM of each dNTP and 200U of superscript
II (Invitrogen). The reaction was made up to a ﬁnal
volume of 20 ml with RNase-free water.
RNA was also isolated from testis and brain using the
TRIzol Reagent (Invitrogen), according to the manufac-
turer’s instructions. The RNA was resuspended in RNase-
free water, the concentration was veriﬁed by absorbance
(A260/280 ratio) on a NanoDrop ND-1000 spectropho-
tometer (NanoDrop), and the samples were stored at
80C. Subsequently, complementary DNA (cDNA)
was synthesized from 0.5mg of total RNA as described
earlier in the text, and the resulting cDNAs were ampliﬁed
by real-time qPCR.
PCR was performed by adding 10 ml of 2X SYBR Green
PCR supermix (Bio-Rad) to each well, along with 4 ml
of the template and 0.0625 mM of each speciﬁc primer
in a total reaction volume of 20 ml. PCR proﬁles were
obtained using the iQ5 Detection System (Bio-Rad) as
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follows: denaturation at 95C for 10min; 50 ampliﬁcation
cycles of 15 s at 95C, 30 s at 61.4C and 1min at 72C. At
the end of each reaction, the cycle threshold (Ct) was
manually set to the level that reﬂected the best PCR
kinetics. Melting curves were then acquired and analysed.
Primer design to quantify the miRNA precursor and
mature molecules
The primers used to analyse the miRNA precursor mol-
ecules were designed as described previously (22). The
same reverse primer, but different forward primers, was
used to amplify each pri- and pre-miRNA. To quantify
the relative expression of the pri-miRNA molecules, the
forward primer was designed 50 to the pre-miRNA hairpin
region. However, as the pre-miRNA molecules are the
result of pri-miRNA cleavage, primers designed to the
stem portion simultaneously amplify both precursor mol-
ecules (pri- and pre-miRNAs). Therefore, to determine the
amount of pre-miRNA, we used the equation reported
previously (22): pre-miRNA=2CT(pri-miRNA+pre-miRNA)
 2CTpri-miRNA.
Commercial stem-loop RT-primers and TaqMan
(Applied Biosystems) qPCR primers were used to
amplify the mature miRNAs, miR-151-3p and miR-1.
Speciﬁc RT primers for the A-to-I-edited miR-151-3p
forms were designed in collaboration with Applied
Biosystems.
RT-qPCR ampliﬁcation of miRNA precursor and
mature molecules
RNA from 10 oocytes or embryos was used to generate
cDNAs by reverse transcription. All reactions were
performed at 16C for 30min, 42C for 30min, 85C for
5min, and they were then held at 4C. The reactions were
performed in a total volume of 15 ml, containing: NP-40
0.1%, 1X RT buffer, 0.25mM of each dNTP, 50U of
MultiScribeTM Reverse Transcriptase (Applied
Biosystems), 38U of RNase inhibitor and the speciﬁc
primer. For precursor molecules, the same primers were
used to retrotranscribe the RNA isolated and to amplify
the cDNAs in qPCR reactions, and they were added at a
ﬁnal concentration of 0.25 mM. To reverse transcribe the
mature miRNA molecules, commercial stem-loop RT
primers were used following the manufacturer’s recom-
mendations (Applied Biosystems).
The qPCR reactions were performed using speciﬁc
TaqMan real-time PCR primers and precursor primers
in an iQ5 thermocycler Detection System (Bio-Rad). The
20 ml PCR reaction volume contained 4.5 ml RT product,
1X TaqMan Universal PCR master mix, 1 ml of primers
and the probe mix of the TaqMan MicroRNA Assay kit.
Reactions were incubated at 95C for 10min, followed
by 45 cycles of 95C for 15 s and 60C for 10min. The
expression of mature miRNAs was determined using the
2Ct method, using U6 as a reference gene.
Cloning and sequencing of the miR-151-3p
precursor molecules
To identify A-to-I changes in the precursor
sequences, PCR products from the analysis of pri- and
pre-miRNA-151 were cloned into pCR2.1-TOPO
vectors (Invitrogen). Random colonies were selected
from each embryonic stage, and the cloned inserts were
sequenced on a GS-FLX sequencer (Roche) to quantify
the A to G (I) changes. We detected three types of precur-
sor molecules: unedited, edited at one speciﬁc position (at
the +3 position) and with two edited nucleotides (at the
1 and+3 positions). The editing rate was estimated after
sequencing, as the proportion of the cDNA clones
containing the A-G change out of the total number of
clones sequenced. From the sequencing data, primers
were designed in collaboration with Applied Biosystems
to amplify the different unedited and edited miRNA
forms.
Speciﬁcity of the probes and primers used to differentiate
unedited versus edited miR-151-3p molecules
The RT-qPCR products were sequenced to evaluate the
speciﬁcity of the primers and TaqMan probes used to dis-
tinguish between unedited and edited miR-151-3p mol-
ecules, which conﬁrmed the speciﬁcity of ampliﬁcation
(Supplementary Figure S2). In addition, the PCR
products identiﬁed were cloned into TOPO vectors, and
DNA from individual clones was extracted using High
Pure Plasmid Isolation Kit (Roche). The DNA extracted
was used as a template to check the primer/probe speciﬁ-
city, performing PCR assays in which the different DNA
templates were cross-reacted with the different primers/
probes to discriminate between the unedited and edited
miR-151-3p isoforms. PCR ampliﬁcation only occurred
when the primers and probes corresponded to their
respective template.
Quantiﬁcation of the absolute number of molecules
Once the speciﬁcity of the miR-151-3p probes had been
tested, we quantiﬁed the absolute number of molecules
by qPCR (23–25). The DNA standards necessary to elab-
orate the calibration curves for the absolute quantiﬁcation
were obtained from PCR products cloned in TOPO
vectors as described earlier in the text. Based on the
known DNA concentrations, a standard curve with differ-
ent dilutions was generated to interpolate the Ct values
for qPCR ampliﬁcation at each biological stage, and con-
sequently, to derive the copy number of each mature
miRNA. The initial number of molecules for standard
DNAs was calculated by Avogadro’s number.
Immunocytochemistry
Oocytes and pre-implantation embryos were ﬁxed with
4% paraformaldehyde for 20min at room temperature
(r.t.). All samples were then treated with 0.2% Triton
X-100 for 10min, washed for 45min in PBS+5% BSA,
and incubated for 1 h at r.t. with a goat polyclonal anti-
Tudor-SN antiserum diluted 1:100 (sc-34753 Santa Cruz
Biotechnology INC). After washing in PBS 1X, the
samples were incubated for 45min at r.t. with a donkey
anti-goat immunoglobulin G-TR secondary antibody
diluted 1:100 (sc-2783 Santa Cruz Biotechnology INC).
After mounting with UltraCruzTM Mounting Medium
(sc-24941 Santa Cruz Biotechnology INC) containing
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DAPI, the samples were visualized on a TCS SP2
Confocal Laser Scanning Microscope (LEICA), and the
images were recorded.
Data analysis
All expression studies involved four biological replicates,
each of which provided sufﬁcient material for four tech-
nical replicates. All the data were normalized using the
delta-Ct method (26), and H2afz and Ppia were used as
the reference genes to normalize the expression of the
ADAR genes and Snd1. U6 was used to normalize the
expression of precursors and mature miRNAs.
Statistical analyses were performed using the PASW
statistics 18 software (SPSS Inc., Chicago, IL).
Parametric statistical analysis [(mean and standard devi-
ation (SD)] were performed on a total of 16 measurements
(four biological replicates each producing four technical
replicates) for each gene studied, at each stage analysed.
One-way ANOVA was performed for multiple compari-
sons. The results of descriptive statistics and post hoc
Tukey’s test with a 95 and 99% mean conﬁdence
interval are shown in the Supplementary Tables S3–S7.
Small RNA isolation, library construction and deep
sequencing analysis
The TRIzol reagent (Invitrogen) was used to isolate total
RNA from each sample, permitting the recovery of small
RNAs (<200 nt). This total RNA was quantiﬁed on a
Nanodrop ND-1000 apparatus (Thermo Scientiﬁc), and
the total RNA used was 0.96mg for oocytes (from 15 210
cells) or 1.6 mg for zygotes (from 15 416 cells). The cDNA
libraries were prepared using the Illumina Small RNA kit
(Illumina), according to the manufacturer’s instructions.
Brieﬂy, small RNAs in the 18–30 nt range were puriﬁed
from each library and recovered on a denaturing poly-
acrylamide gel electrophoresis gel. Adaptors for reverse
transcription and ampliﬁcation were then ligated to the
50 and 30 ends, and the modiﬁed RNAs were reverse
transcribed to cDNA and PCR-ampliﬁed. After the
cDNAs were puriﬁed and recovered on a denaturing poly-
acrylamide gel electrophoresis gel, the purity and concen-
tration of the samples were determined using a Nanodrop
ND-1000 apparatus. Sequencing was performed, and
libraries were constructed using an Illumina HiSeq2000
Genome Analyzer (DNAVision).
Sequential alignments of the sequenced reads against a
number of miRBase database v.16 entries were performed
using CLC Genomics Workbench v.4.06 software
(CLCbio). Target prediction was analysed using Target
Scan algorithms (http://www.targetscan.org/mmu_50/).
RESULTS
Regulated expression of the ADAR gene family
To assess the regulation and involvement of ADAR
proteins in the editing of miRNAs in oocytes, and during
the different stages of pre-implantation development (from
the zygote to blastocyst), the expression of the ADAR
genes was quantiﬁed by RT-qPCR. As the strongest
expression of ADAR genes was detected in the brain and
testis, and as most targets of A-to-I editing are found in the
nervous system (27), the expression of the ADAR genes in
oocytes and embryos was compared with that in these
tissues. These analyses showed that unlike the brain,
where all the genes of this family were expressed abun-
dantly, Adar1p110 was the only ADAR gene expressed at
the developmental stages examined, mainly in oocytes and
zygotes (Figure 1). However, the accumulation of
Adar1p110 transcripts in oocytes and zygotes was around
twice that detected in the brain, and >10 times that
detected in testis. To our knowledge, these are the highest
levels of Adar1p110 detected in any tissue or cell type,
indicative that there is very active RNA editing by
ADAR1p110 during the perifertilization period.
Through translational repression followed by mRNA
decay, miRNAs can regulate the accumulation of their
target transcripts (28–30). Interestingly, miR-1 is a
negative regulator of both Adar1 mRNAs (18). Hence,
Adar1 gene regulation was studied in oocytes and early
embryos, and the participation of miR-1 in the rapid
decline of Adar1p110 transcripts after fertilization was
analysed. An inverse correlation was detected between
Adar1p110 and miR-1 expression, except in the morula
where both Adar1p110 transcripts and miR-1 were
present at very low levels for reasons that are not yet
clear. By contrast, the highest levels of miR-1 were
detected in 4-cell embryos, in which very little
Adar1p110 mRNA accumulated (Supplementary Figure
S1). This suggests an active regulatory role for miR-1 in
the editing of miRNAs in the early embryo, mediated by
the negative regulation of Adar1 transcripts.
The biogenesis and editing dynamics of miR-151-3p
To determine whether the dynamics of Adar1p110 regula-
tion had any impact on the editing of speciﬁc miRNAs
during pre-implantation development, the biogenesis and
editing of miR-151-3p, a representative miRNA in which
Figure 1. Relative expression of genes in the Adar family. Expression
of the Adar1p110 (Adar1s), Adar1p150 (Adar1l), Adar2 (Adarb1) and
Adar3 (Adarb2) genes in oocytes and during pre-implantation develop-
ment. RT-qPCR data were obtained from oocytes, and all pre-
implantation development stages up to the blastocyst, as well as from
testis and brain. Ppia and H2afz were used as reference genes, and in
all the samples, the data represent the mean of 16 replicates±SD.
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editing has been described in nerve cells (10,31,32) and
which we conﬁrmed to be present in early embryos, was
studied from the oocyte to blastocyst stages. The accumu-
lation of the successive forms of this miRNA (i.e. pri-
miRNA, pre-miRNA and the canonical non-edited
mature form) was analysed by RT-qPCR, with the
highest levels of pri-miRNA-151 detected in oocytes and
zygotes. However, the relatively low levels of pre- and
mature forms detected at these stages were not consistent
with these high levels of the pri-miRNA form (Figure 2A).
An analysis of the accumulation of the precursor and
mature forms showed an increase in pre-miRNA in
2-cell stage embryos, and an increase in the mature form
at the 4-cell stage (Figure 2A). These results might reﬂect
the processing of pri-miRNA accumulated in oocytes and
zygotes over successive developmental stages.
Given the predominant expression of Adar1p110 in
oocytes and zygotes, the maternally inherited pri-
miRNAs might be subject to a high rate of A-to-I
edition and removal such that they are consequently not
processed to pre-miRNAs. By contrast, the relative
increase in the rate of unedited pri-miRNA accumulation
in successive developmental stages might allow processing
to pre- and mature miRNAs, as detected in the 2- and
4-cell embryos. To test this hypothesis, we ﬁrst cloned
and sequenced 85 cDNAs from the miR-151 precursor
Figure 2. Analysis of miR-151 biogenesis. (A) The expression of precursor (pri- and pre-) and mature forms of miR-151-3p was assessed by
RT-qPCR to evaluate the biogenesis of miR-151-3p. The variation in the expression of the precursor forms did not correspond to that of the
mature forms, suggesting the elimination of potentially edited precursor molecules at early embryonic stages. The right-hand scale represents the
proportion of edited precursor molecules found by the cloning and sequencing of 85 cDNAs from miR-151 precursors. (B) The dynamics of A-to-I
editing in the precursor molecules of miR-151 was analysed from the oocyte to blastocyst stage of development. The arrowheads indicate the edited
sites found in miR-151 precursor molecules, which were detected as A to G changes in the DNA sequencing chromatogram. The edited sites are
located at position+3 within the sequence of mature miR-151-3p and at position 1 outside the mature miRNA sequence. (C) Comparative analysis
of miR-151-3p expression and the absolute quantiﬁcation of mature unedited and edited miR-151-3p molecules. Grey bars represent the unedited
mature miR-151-3p expression, whereas the red and cyan bars represent the ‘one edition’ site (position+3) and the ‘two edition’ sites (positions+3
and 1) of miR-151-3p molecules, respectively. (D) Editing rates detected in mature miR-151-3p molecules from oocytes and zygotes using deep
sequencing approaches.
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molecules at different stages of pre-implantation develop-
ment (at least 10 cDNA clones corresponding to miRNA
precursors were selected at random from each stage and
sequenced). As previously reported in other cell types (10),
as well as unedited molecules, A-to-I-edition (manifested
as A-to-G) at the+3 position of miR-151-3p was identiﬁed
and in some of the molecules sequenced, editing at
position 1 also occurred (1 nt away from the canonical
mature form of miR-151-3p: Figure 2B). All three mol-
ecules were detected at the developmental stages
examined, except in oocytes and 8-cell embryos in which
only the edited molecules were identiﬁed, and in zygotes,
in which only unedited precursor forms were detected
(Figure 2A). This indicates that active editing occurs,
with the edited precursors of miR-151 eliminated in the
transition from the unfertilized oocyte to zygote.
To conﬁrm these ﬁndings and to deﬁne the dynamics of
the elimination and conservation of edited precursor to
produce mature miRNAs carrying A-to-I edition,
speciﬁc stem-loop RT-PCR primers (33) and TaqMan
probes were designed. To design these primers, we took
into account the three types of potential mature
miR-151-3p molecules detected: unedited; with one
edition at the +3 position; and edited at the +3 and 1
positions (Figure 2C). The speciﬁcity of the primers and
probes was assessed by sequencing the PCR products
obtained and in assays using cDNA templates of the dif-
ferent edited and unedited molecules (see ‘Materials and
Methods’ section). After RT-qPCR, the absolute number
of molecules per 10 cells or embryos was calculated
for the different pre-implantation stages studied
(see ‘Materials and Methods’ section). The results
Figure 3. Frequency of A-to-I editing in different mature miRNAs detected by deep sequencing analysis of oocytes and zygotes. (A–G) The
arrowheads indicate the edited site in the precursor molecule, and the proportion of edited and unedited molecules is shown in parentheses. The
A-to-G change is indicated by highlighting the capital letter in the mature sequence. Precursor sequences were obtained from the Sanger Center
miRBase Site.
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corroborated those of the relative distribution during
development for the unedited form of miR-151-3p
(Figure 2C), providing an estimation of the molecular
dynamics of miR-151-3p biogenesis and editing. The
detailed analysis of the three forms at each pre-implant-
ation stage indicated that only a small proportion of miR-
151-3p molecules were edited at the+3 position, and very
few molecules were edited at the two positions, except
at the 2-cell stage. In these embryos, there was a higher
proportion of miR-151-3p with one edition at the +3
position than of the unedited miRNA form (Figure 2C).
This increase in the edited form was coincident with the
decline seen in pri-miRNA and the increase seen in pre-
miRNA, suggesting that the abundance of pre-miRNA
forms circumvented the potential elimination of the
edited precursors, which become edited mature miRNAs.
From the deep sequencing of small RNAs in oocytes
and zygotes (>50 million reads for each cell type: manu-
script in preparation), we extracted data for miR-151-3p
and other editable miRNAs. The results conﬁrmed the low
levels of A-to-I edited miR-151-3p compared with the
unedited molecules (Figure 2D), corroborating the RT-
qPCR analysis presented here. Additionally, the editing
rate of other miRNAs previously shown to be edited in
the brain was examined in oocytes and zygotes where
Adar1p110 is expressed most strongly (Figure 1). From
33 mouse homologues of human miRNAs (32), another
7 miRNAs were expressed in oocytes or zygotes and were
examined (>100 reads): miR-376a, let7-g, miR-27a, miR-
411, miR-379, miR-376b-3p and miR-376b-5p (Figure 3).
Among all these miRNAs, few or no mature edited forms
were expressed in oocytes and zygotes as opposed to the
unedited molecules (Figure 3). Globally, these results
strongly suggest a reprogramming of A-to-I edition and
the degradation of these miRNA precursors after
fertilization.
The ﬁnding of edited nucleotides inside and outside the
seed regions suggests that edition may cause the
retargeting of some miRNAs (31,34). To test this hypoth-
esis, we examined the retargeting that might occur after
miR-411 and miR-376b-3p editing in oocytes and zygotes,
where these miRNAs showing the highest rate of editing in
the seed region (Figure 3D and F). The use of TargetScan
prediction software identiﬁed 48 genes as putative targets
for canonical miR-411 and 112 genes for miR-376b-3p. By
contrast, we found 32 genes that could be the targets of
edited miR-411 and 212 genes targeted by the edited miR-
376b-3p (Supplementary Tables S1 and S2). Signiﬁcantly,
there were no common target genes for unedited and
edited miR-411, and just three of genes were identiﬁed in
both the unedited and edited miR-376b-3p target lists. This
indicates that editing mechanisms may also generate alter-
native seed regions for some miRNAs, and that these
mechanisms would inﬂuence the gene regulation
mediated by miRNAs, increasing the number of targets
potentially subjected to such regulation.
Tudor-SN and the degradation of miRNA precursors
As editing by ADAR could reﬂect the rate of degradation
of edited double-stranded RNAs, the expression of Snd1,
the gene encoding the protein Tudor-SN, was assessed.
Through the recognition of inosine residues, Tudor-SN
is involved in the degradation of hyperedited RNAs,
including miRNAs, (12). The Snd1 gene was most
strongly expressed in oocytes and zygotes, 6- and 2-
fold the expression detected in brain or testis (Figure 4).
These results were consistent with the co-regulation by
hyperediting and the degradation of tagged molecules as
a post-transcriptional mechanism to modulate miRNA
precursors, mainly in the oocyte-to-zygote transition.
The cellular distribution of Tudor-SN was examined by
immunoﬂuorescence in oocytes and embryos up to the
blastocyst stage. Tudor-SN immunostaining showed a
speckled pattern in the nucleus and cytoplasm of
oocytes, zygotes and embryos up to the 8-cell stage, as
well as accumulating in small granules in the cytoplasm
of oocytes and the early zygote. In the morula and blasto-
cyst stages, large aggregates of Tudor-SN were observed
(Figure 5), which we describe here for the ﬁrst time,
and we refer to as ‘T-bodies’ (from Tudor-SN-bodies).
The functional role of these changes in the distribution
and conformation of T-bodies is unknown, and nor is
it clear whether they might appear during the differenti-
ation or development of other cell types. However, the
role of Tudor-SN suggests that T-bodies could be foci
for the accumulation and degradation of hyperedited
molecules.
DISCUSSION
The role of ADAR proteins in the editing of mRNAs has
been mainly studied in the nervous system (35–38). More
recently, ADAR-mediated modulation of A-to-I editing in
miRNAs generated new perspectives on gene regulation
during development and differentiation (5,39–42), even
during the embryonic period (34). However, to our know-
ledge, this is the ﬁrst time such modulation has been
analysed in fertilization and pre-implantation
development.
Figure 4. Snd1 expression levels. Relative expression of the gene
encoding the Tudor-SN protein obtained by RT-qPCR analysis using
Ppia and H2afz as reference genes to normalize the data. The results
are the mean of 16 replicates±SD.
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Adar1p110 and Snd1 are strongly expressed by oocytes
and zygotes. It was previously suggested that miRNA
activity is largely suppressed in the early stages of pre-
implantation development (43). Therefore, it is not
strange that mechanisms such as A-to-I editing followed
by the elimination of hyperedited miRNA precursors
should be upregulated during the perifertilization period.
ADAR1 has been demonstrated to be essential during
embryogenesis (44). Although Adar1p150 is induced by
interferon, and this protein is present in both the
nucleus and cytoplasm, Adar1p110 is constitutively ex-
pressed, and this protein is found in the nucleus (45–47).
We have detected miRNA editing in conjunction with
strong Adar1p110 expression in oocytes and zygotes but
not of that of other ADAR genes, suggesting that this
ADAR isoform seems to be sufﬁcient for the editing
that occurs in the pre-implantation stages examined.
The biogenesis and function of miRNAs can be
altered by A-to-I editing. However, Adar transcripts
are themselves the targets of several miRNAs, one of
Figure 5. Immunolocalization of Tudor-SN (red) during pre-implantation development. The white arrowheads indicate the presence of ‘T-bodies’.
All nuclei (blue) were counterstained by DAPI (4,6-diamidino-2-phenylindole). Pre-implantation stages analysed: (A) Oocyte; (B) early zygote; (C)
syngamy zygote; (D) 2-cell embryo; (E) 4-cell embryo; (F–G) 6 to 9-cell embryo; (H–I) early and late morula; (J–L) blastocyst; (M–P) negative
control. Scale bars represent 20 mm.
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which is miR-1. The expression of Adar1 is downregulated
by this miRNA (18), which might possibly play a key role
in the development of the embryonic heart (19). In the
present work, increased miR-1 levels were observed in
embryos after the 2-cell stage, coinciding with a fall in
Adar transcripts. These results corroborate the active
regulation of ADAR by miR-1, even when only a single
isoform of ADAR is expressed, as observed during pre-
implantation development.
It has been reported that disrupting both Adar1
isoforms causes embryonic lethality in mice at about
11.5 days post coitum (44,48). Thus, although the data
suggest a minor role for ADAR proteins in pre-implant-
ation development, they appear to fulﬁll an essential role
during the development of the haematopoietic system
(44,48). Here, RT-qPCR studies showed Adar1p110 to
be strongly expressed in oocytes and zygotes, diminishing
at successive pre-implantation stages. This suggests that
precursor editing may preferentially occur in the oocyte
and zygote. ADAR1/ mice could circumvent the
absence in ADAR during the very early stages of pre-
implantation development owing to the maternal provi-
sion of Adar1p110 in oocytes from the ADAR1+/
heterozygotic dams used to generation the null mutant
offspring (44).
Although ADAR proteins mark the miRNA precursor
molecules with inosine, the degradation of hyperedited
precursors, as for other double-stranded RNAs, is
carried out by Tudor-SN (encoded by Snd1) (12). Like
Adar1p110, the highest level of Snd1 expression was
detected in the oocyte and zygote, although immunocyto-
chemical analysis revealed Tudor-SN protein to be present
at all pre-implantation stages. The high maternal and
zygotic expression, coupled to the stability of Tudor-SN,
might explain the distinct distribution of the mRNA tran-
scripts and protein. Other proteins behave similarly during
pre-implantation development. For example, Nalp5 tran-
scripts accumulate strongly in oocytes; yet, they diminish
over successive stages (49), whereas the corresponding
protein is detected at all stages. Nevertheless, the
presence of discrete granules of Tudor-SN in oocytes
and zygotes, and later in morulae and blastocysts, might
reﬂect different activities of the protein.
If these T-bodies represent the cellular foci where edited
precursor miRNA molecules are eliminated, there may be
two important moments during mouse pre-implantation
development when edited RNAs are erased, the ﬁrst
during the transition from the oocyte to zygote, and the
second in the morula and blastocyst stages. It has been
postulated that Tudor-SN may degrade RNA in associ-
ation with other components of the cell machinery, the
products being grouped in discrete foci known as
P-bodies (50). However, Tudor-SN has not been identiﬁed
in P-bodies (51), and we were unable to ﬁnd Tudor-SN in
such structures [identiﬁed with an antibody against
DCP1a: (52,53)] during pre-implantation development
or in cultured cells (data not shown). Consequently, the
dynamic conﬁguration and cellular localization of Tudor-
SN appears to be distinct to that of other RNA degrad-
ation foci, displaying an independent conﬁguration as
‘T-bodies’ in pre-implantation embryos.
The activity of ADAR1 in meiotic progression after fer-
tilization might also be mediated by NF90/NF45 (encoded
by the Ilf3 and Ilf2 genes, respectively). NF90 and NF45
contain a double-stranded RNA-binding motif, as do
DROSHA and DGCR8 (54–56), key elements for pri-
miRNA processing. NF90/NF45 are negative regulators
of the ﬁrst step in the transition from pri-miRNAs to pre-
miRNAs (57). Consequently, the accumulation of pri-
miRNAs might establish a feedback loop and facilitate
the activity of ADAR. However, ADAR also regulates
nuclear factors of the NF90 protein family, and ADAR1
interacts with NF45/NF90 leading to the upregulation
of NF90 target genes (58). DNA-Pk (encoding DNA-
dependent protein kinase) is in turn regulated by NF90/
NF45 (59,60). This kinase is involved in double-strand
break repair, which represents a key check point in
meiotic progression. We previously reported that NF90
(Ilf3) and NF45 (Ilf2) are expressed strongly in mouse
meiotic cells, and that the proteins they encode are
localized in the nucleus of both spermatocytes and
oocytes. Interestingly, NF90 and NF45 only associate
with the chromatin involved in chromosome synapses,
and consequently double-strand breaks, but not in the
XY body of spermatocytes (61). Thus, although the role
of these proteins in the editing and processing of miRNAs
during oogenesis and early embryo development appears
to be of great interest, extensive work will be required to
fully decipher how these events are controlled.
Together, the data presented here indicate that ADAR
and Tudor-SN participate in the A-to-I editing and elim-
ination of miRNA precursors, respectively, which occurs
in the progression from the oocyte to zygote, before the
activation of the zygotic genome that occurs in 2 cell stage
mouse embryos. The data reported here suggest that there
is signiﬁcant erasure of edited miRNA precursors
post-fertilization such that most edited precursors do not
generate mature molecules. However, some edited
miRNAs, such as miR-411, miR-376b-3p (34,62,63), may
acquire new targets and perhaps act in new biological
pathways. Thus, the expression of Adar1 and Snd1
during oogenesis could be decisive, both in the formation
of the oocyte and in the initial stages of differentiation
after syngamy.
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